Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 285,442 | 209,958 | 139,739 | 89,734 | 263,099 |
| Depreciation Amortization | 107,238 | 80,315 | 53,344 | 26,641 | 101,069 |
| Income taxes - deferred | -29,567 | -22,651 | -6,365 | -4,767 | 6,816 |
| Accounts receivable | -20,867 | -20,775 | 11,425 | 17,335 | -57,596 |
| Accounts payable and accrued liabilities | -7,908 | -5,647 | -11,541 | -1,401 | 12,741 |
| Other Working Capital | -90,577 | -79,706 | -40,313 | -22,932 | -69,517 |
| Other Operating Activity | 10,632 | 9,506 | -25,824 | -48,529 | 68,660 |
| Operating Cash Flow | $254,393 | $171,000 | $120,465 | $56,081 | $325,272 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,736 | 8,661 | 6,009 | 9 | -26,943 |
| PPE Investments | -38,244 | -27,413 | -15,665 | -9,556 | -44,908 |
| Net Acquisitions | -101,184 | -101,184 | -101,184 | -101,184 | N/A |
| Purchase Of Investment | N/A | -232,000 | N/A | N/A | -25,000 |
| Sale Of Investment | 91,043 | 91,043 | 91,043 | 91,043 | N/A |
| Other Investing Activity | -232,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-265,649 | $-260,893 | $-19,797 | $-19,688 | $-96,851 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 619,661 | 619,661 | 449,661 | 449,661 | 90,000 |
| Debt Repayment | -525,661 | -505,661 | -505,661 | -441,000 | -175,500 |
| Common Stock Issued | 29,813 | 21,399 | 16,977 | 11,950 | 77,155 |
| Common Stock Repurchased | -19,562 | -19,562 | -19,562 | -19,562 | -160,950 |
| Dividend Paid | -50,285 | -37,688 | -25,106 | -12,545 | -50,185 |
| Other Financing Activity | -31,350 | -31,311 | -20,310 | -20,310 | -23,373 |
| Financing Cash Flow | $22,616 | $46,838 | $-104,001 | $-31,806 | $-242,853 |
| Exchange Rate Effect | -3,356 | -2,230 | -4,552 | -11,897 | -12,092 |
| Beginning Cash Position | 172,567 | 172,567 | 172,567 | 172,567 | 199,091 |
| End Cash Position | 180,571 | 127,282 | 164,682 | 165,257 | 172,567 |
| Net Cash Flow | $8,004 | $-45,285 | $-7,885 | $-7,310 | $-26,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | 254,393 | 171,000 | 120,465 | 56,081 | 325,272 |
| Capital Expenditure | -38,244 | -27,413 | -15,665 | -9,556 | -44,908 |
| Free Cash Flow | 216,149 | 143,587 | 104,800 | 46,525 | 280,364 |